Jeisys Medical (XKRX:287410) Ending Cash Position : ₩52,937 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Jeisys Medical Ending Cash Position?

Jeisys Medical's Ending Cash Position for the quarter that ended in Jun. 2024 was ₩52,937 Mil.

Jeisys Medical's quarterly Ending Cash Position increased from Dec. 2023 (₩48,830 Mil) to Mar. 2024 (₩96,583 Mil) but then declined from Mar. 2024 (₩96,583 Mil) to Jun. 2024 (₩52,937 Mil).

Jeisys Medical's annual Ending Cash Position increased from Dec. 2021 (₩34,291 Mil) to Dec. 2022 (₩39,583 Mil) and increased from Dec. 2022 (₩39,583 Mil) to Dec. 2023 (₩48,830 Mil).

Jeisys Medical Ending Cash Position Historical Data

The historical data trend for Jeisys Medical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeisys Medical Ending Cash Position Chart

Jeisys Medical Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

1,115.86

17,590.65

34,291.11

39,582.85

48,830.21

Jeisys Medical Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Ending Cash Position	Get a 7-Day Free Trial															52,593.29	41,436.23	48,830.21	96,582.77	52,936.74

Jeisys Medical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Jeisys Medical's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	39582.851	+	9247.356
	=	48,830

Jeisys Medical's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	96582.767	+	-43646.03
	=	52,937

Jeisys Medical Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Jeisys Medical's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeisys Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jeisys Medical Inc (XKRX:287410) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 Eulji-ro, Jung-gu, Seoul, KOR, 04538

Website

https://www.jeisys.com

Jeisys Medical Inc is a medical device manufacturer that produces high-end products for plastic surgeons, dermatologists, physicians, and healthcare professionals. Some of its products include ULTRAcel Q+ system, Cellec V system, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, and SmoothCool.

Jeisys Medical Headlines

No Headlines